Uppsala's 'smart' robot tests new cancer drug combos

Researchers at Uppsala University in Sweden have developed a robot that can assess various combination therapies for cancer, analyzing the results and flagging their potential as new therapies. "We have built a robot system that plans and conducts experiments with many substances, and draws its own conclusions from the results," said Dr. Claes Andersson, a leading scientist on the project, in a release. "The idea is to gradually refine combinations of substances so that they kill cancer cells without harming healthy cells." Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.